UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma

International journal of hematology, 2012-08, Vol.96 (2), p.254-262

2012

Link zum Volltext

Verfügbarkeit prüfen

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

The New England journal of medicine, 2015-01, Vol.372 (2), p.142-152

2015

Link zum Volltext

Verfügbarkeit prüfen

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The New England journal of medicine, 2020-12, Vol.383 (26), p.2526-2537

2020

Link zum Volltext

Verfügbarkeit prüfen

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

The New England journal of medicine, 2016-10, Vol.375 (14), p.1319-1331

2016

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

The New England journal of medicine, 2007-11, Vol.357 (21), p.2123-2132

2007

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia

British journal of haematology, 2017-02, Vol.176 (4), p.618-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Successful Use of Nilotinib in the Therapy of a Patient with a Chemoresistant Relapse of BCR-ABL1-Like Phenotype Acute Lymphoblastic Leukemia

Oncology research and treatment, 2018-01, Vol.41 (9), p.550-553

2018

Link zum Volltext

Verfügbarkeit prüfen

Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study

Haematologica (Roma), 2015-08, Vol.100 (8), p.e311-e314

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant

Leukemia & lymphoma, 2013-05, Vol.54 (5), p.973-978

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients

Annals of oncology, 2004-08, Vol.15 (8), p.1222-1230

2004

Link zum Volltext

Verfügbarkeit prüfen

A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemotherapy

Haematologica (Roma), 2007-04, Vol.92 (4), p.493-501

2007

Link zum Volltext

Verfügbarkeit prüfen

Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma

Medical science monitor, 2002-04, Vol.8 (4), p.PI31

2002

Link zum Volltext

Verfügbarkeit prüfen

Saliva secretion and abnormal moistening of oral mucosa after bone marrow transplantation

Bulletin du Groupement international pour la recherche scientifique en stomatologie & odontologie, 2006-03, Vol.47 (1), p.1-5

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Lymphoma, Myeloma And Leukemia

ThemaAntineoplastic Combined Chemotherapy Protocols - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(23)
Life Sciences & Biomedicine
(21)
Middle Aged
(21)
Science & Technology
(21)
Female
(20)
Male
(19)
Adult
(17)
Aged
(13)
Treatment Outcome
(12)
Aged, 80 And Over
(10)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(10)
Hematology
(10)
Oncology
(9)
Recurrence
(9)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Young Adult
(8)
Remission Induction
(7)
Adolescent
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study

Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)

Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia

Successful Use of Nilotinib in the Therapy of a Patient with a Chemoresistant Relapse of BCR-ABL1-Like Phenotype Acute Lymphoblastic Leukemia

Status of minimal residual disease after induction predicts outcome in both standard and high‐risk Ph‐negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4‐2002 MRD Study

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial

Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis

Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG)

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients

A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemotherapy

Impact of granulocyte colony stimulating factor administered during induction and consolidation of adults with acute lymphoblastic leukemia on survival: long-term follow-up of the Polish adult leukemia group 4-96 study

Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1)

Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma

Saliva secretion and abnormal moistening of oral mucosa after bone marrow transplantation

Aktive Filter

Suchergebnisse filtern